Duck cells for Ebola vaccine production: ProBioGen highlights Emergent's use of tech for MVA EBOZ
Emergent Biosolutions’ Ebola vaccine is the first to be made in cells rather than the hens’ eggs according to production tech developer ProBioGen.
Archives for June 8, 2015
Green Cross constructing $255m Canadian immunoglobulin and albumin plant
Green Cross Biotherapeutics has begun constructing a facility in Canada it says will produce up to five tons of injectable antibodies and 25,000kg of albumin annually.
Single-use demonstration sites 'needed more than ever' says Sartorius
Sartorius says application centres are integral to demonstrate its single-use technologies as it opens a third in New York.